Treatment-limiting decisions occurred in nearly half of patients with severe TBI and the prevalence of such decisions has increased over time.
Countries with COVID-19 pandemic-associated reductions in childhood immunization coverage have not yet recovered.
New data suggest that the United States launches the most new cancer drugs of any other country and is most likely to launch cancer drugs first.